Possible association of psoriasis and reduced bone mineral density due to increased TNF-α and IL-6 concentrations

被引:46
作者
Kastelan, Darko
Kastelan, Marija
Massari, Lara Prpic
Korsic, Mirko
机构
[1] Univ Zagreb, Univ Hosp, Dept Internal Med, Div Endocrinol, Zagreb 10000, Croatia
[2] Univ Rijeka, Fac Med, Dept Dermatol, Rijeka 51000, Croatia
关键词
D O I
10.1016/j.mehy.2006.04.069
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Psoriasis is a chronic erythematosquamous disease affecting about 2-3% of the population. It is generally considered to be a T cell-mediated disorder. Psoriasis is characterized by Th1-type cytokine pattern with the predominant secretion of IL-2, IL-6, IFN-gamma and TNF-alpha. Such cytokine pattern is sufficient in inducing keratinocyte hyperproliferation, a hallmark of psoriasis. It seems that development of psoriatic Lesions is mediated by TNF-alpha and proliferation of local T cells is dependent on local TNF-a production. IL-6 enhances activation, proliferation and chemotaxis of T cells into psoriatic lesions. It is also a direct keratinocyte mitogen that could directly stimulate keratinocyte proliferation. Data of possible association between psoriasis and reduced bone mineral density (BMD) are Limited and therefore, not fully conclusive. The major limitation of two studies reported so far was small sample size. Based on increased concentrations of TNF-alpha and IL-6 in psoriasis we hypothesized that these patients are more prone to osteoporosis than healthy subjects. TNF-alpha enhances bone resorption via stimulating osteoclast development and activity as well as bone formation. On the other hand, IL-6 is also a potent stimulator of bone resorption. Moreover, increased production of TNF-alpha and IL-6 has been found in postmenopausal women with osteoporosis. Several lines of evidence support our hypothesis; higher value of IL-6 was recorded in children with idiopathic osteoporosis than in healthy controls; TNF-a knock-out mice do not lose bone after ovariectomy; polymorphism of TNFRSF1B gene which encodes 75Kd TNF receptor is associated with BMD; treatment with anti-TNF-alpha antibody exert beneficial effect on bone metabolism in patients with rheumatoid arthritis and finally, raloxifene inhibit osteoclast activity by reducing TNF-alpha and IL-6 synthesis. However, our hypothesis raised number of questions. Are increased serum concentrations of TNF-alpha and IL-6 mirrored by increased concentrations of these cytokines on the local level? Furthermore, could other cytokines relevant in the pathogenesis of the psoriasis, first of all IFN-gamma, modulate the risk of osteoporosis? Thus, a large prospective, case-control study with the data on BMD, biochemical parameters of bone turnover and fractures have to be done to test our hypothesis. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1403 / 1405
页数:3
相关论文
共 20 条
[1]
STIMULATION OF BONE-RESORPTION AND INHIBITION OF BONE-FORMATION INVITRO BY HUMAN-TUMOR NECROSIS FACTORS [J].
BERTOLINI, DR ;
NEDWIN, GE ;
BRINGMAN, TS ;
SMITH, DD ;
MUNDY, GR .
NATURE, 1986, 319 (6053) :516-518
[2]
Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α [J].
Boyman, O ;
Hefti, HP ;
Conrad, C ;
Nickoloff, BJ ;
Suter, M ;
Nestle, FO .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (05) :731-736
[3]
Raloxifene modulates interleukin-6 and tumor necrosis factor-α synthesis in vivo:: results from a pilot clinical study -: Comment [J].
Gianni, W ;
Ricci, A ;
Gazzaniga, P ;
Brama, M ;
Pietropaolo, M ;
Votano, S ;
Patanè, F ;
Aglianò, AM ;
Spera, G ;
Marigliano, V ;
Ammendola, S ;
Agnusdei, D ;
Migliaccio, S ;
Scandurra, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (12) :6097-6099
[4]
Psoriasis [J].
Greb, Jacqueline E. ;
Goldminz, Ari M. ;
Elder, James T. ;
Lebwohl, Mark G. ;
Gladman, DafnaD. ;
Wu, Jashin J. ;
Mehta, Nehal N. ;
Finlay, Andrew Y. ;
Gottlieb, Alice B. .
NATURE REVIEWS DISEASE PRIMERS, 2016, 2
[5]
CYTOKINES AND ESTROGEN IN BONE - ANTI-OSTEOPOROTIC EFFECTS [J].
HOROWITZ, MC .
SCIENCE, 1993, 260 (5108) :626-627
[6]
INCREASED OSTEOCLAST DEVELOPMENT AFTER ESTROGEN LOSS - MEDIATION BY INTERLEUKIN-6 [J].
JILKA, RL ;
HANGOC, G ;
GIRASOLE, G ;
PASSERI, G ;
WILLIAMS, DC ;
ABRAMS, JS ;
BOYCE, B ;
BROXMEYER, H ;
MANOLAGAS, SC .
SCIENCE, 1992, 257 (5066) :88-91
[7]
Kirby B, 2001, BRIT J DERMATOL, V144, P37, DOI 10.1046/j.1365-2133.2001.00037.x
[8]
Psoriasis pathophysiology: current concepts of pathogenesis [J].
Krueger, JG ;
Bowcock, A .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 :30-36
[9]
The immunologic basis for the treatment of psoriasis with new biologic agents [J].
Krueger, JG .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (01) :1-23
[10]
Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-α antibody:: a prospective open-label pilot study [J].
Lange, U ;
Teichmann, J ;
Müller-Ladner, U ;
Strunk, J .
RHEUMATOLOGY, 2005, 44 (12) :1546-1548